Clinical Trials Logo

Mortality clinical trials

View clinical trials related to Mortality.

Filter by:

NCT ID: NCT04826848 Completed - Pneumonia Clinical Trials

Lactate Clearance in Hospital-acquired Pneumonia

Start date: June 1, 2019
Study type: Observational

There is no clear consensus on the use of pneumonia severity index (PSI) developed for community-acquired pneumonia in hospital-acquired pneumonia cases. In another aspect, PSI is a relatively difficult scoring system that includes many parameters. This study evaluated whether lactate clearance could be used as a mortality marker instead of PSI in hospital-acquired pneumonia. As a result, lactate clearance was lower in the mortal group and when the diagnostic statistics were evaluated, it was seen that the sensitivity and specificity rates were significantly higher. In conclusion, lactate clearance has been evaluated as a strong predictor of mortality in hospital-acquired pneumonia.

NCT ID: NCT04800770 Recruiting - Covid19 Clinical Trials

The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU

Start date: March 3, 2021
Study type: Observational [Patient Registry]

The investigators aimed to investigate the relationship between phosphate level and mortality using the 4C Mortality Score in COVID-19 patients who were followed up in the intensive care unit.

NCT ID: NCT04792736 Completed - Mortality Clinical Trials

Prognostic Value of Lactates in ICU

Start date: June 1, 2019
Study type: Observational

he aim of this prospective, analytic trial was to evaluate the accuracy of blood lactates levels in predicting mortality in ICU patients.

NCT ID: NCT04778735 Recruiting - Clinical trials for Liver Transplantation

Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation

Start date: February 24, 2021
Phase: N/A
Study type: Interventional

The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.

NCT ID: NCT04774991 Not yet recruiting - Mortality Clinical Trials

Azithromycin for Child Survival in Niger: Delivery Trial

Start date: May 2021
Phase: Phase 4
Study type: Interventional

This cluster-randomized trial aims to compare the impact of different delivery approaches to azithromycin distribution on coverage, costs, and feasibility outcomes. The investigators hypothesize that door-to-door delivery will have higher coverage and costs and similar feasibility and acceptability compared to fixed-point delivery.

NCT ID: NCT04750915 Active, not recruiting - Cancer Clinical Trials

NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data

Start date: February 9, 2021
Study type: Observational

Background: The NIH and the American Association of Retired Persons (AARP) conducted a Diet and Health Study. It studied the links between diet, cancer, and cause of death in a group of middle-aged people in the U.S. Researchers want to learn more about how diet and lifestyle can affect cancer and mortality. Objective: To clarify links between diet, lifestyle, cancer, death, and chronic diseases. Eligibility: AARP members ages 50 to 71 who took part in study #OH95CN025 and lived in California, Florida, Pennsylvania, New Jersey, North Carolina, Louisiana, Atlanta, or Detroit in 1995 1996. Design: This study will use existing data and samples. Participants will not be contacted. Participants personal data, like name, date of birth, and address, will be used. This data will be kept private. Their data and samples will get a unique ID. Data from other follow-up studies will be used. Cancer outcome data will be obtained from the 8 sample areas. Many participants have moved to Arizona, Nevada, and Texas. Data will be obtained from those states as well. Cause of death and date of death will be obtained from the National Death Index. Cheek swab samples were gathered from 2004 to 2005. They will be used to study the oral microbiome. The University of Washington (UW) will be added as a study site. UW will study air pollution. The process of linking with the Virtual Pooled Registry Cancer Linkage System will be explored. It uses one system. Right now, 11 state systems are used to get and link data. Paper records will be stored in locked file rooms. Electronic data will be stored on secure servers.

NCT ID: NCT04740619 Completed - Mortality Clinical Trials

Natural Orifice Specimen Extraction in Sigmoid Volvulus

Start date: January 1, 2018
Study type: Observational

Sigmoid resection can be performed using conventional and laparoscopic methods. There are few publications in the literature reporting specimen removal from the natural hole in patients with a diagnosis of sigmoid volvulus. Here, the investigators aimed to present the literature that transanal specimen removal is a technically feasible method after laparoscopic surgery in patients with sigmoid volvulus.

NCT ID: NCT04724044 Not yet recruiting - Sepsis Clinical Trials

Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia

Start date: January 20, 2021
Phase: Phase 3
Study type: Interventional

Traditional management of community-acquired pneumonia (CAP) relies on the prompt administration of antimicrobials that target the most common causative pathogens. Retrospective analysis of observational clinical studies in CAP showed that the addition of macrolides to standard antibiotic therapy conferred a significant survival benefit. The proposed benefit of macrolides is coming from their anti-inflammatory mode of action. An RCT that proves the attenuation of the high inflammatory burden of the host with CAP after addition of clarithromycin in the treatment regimen is missing. This RCT is aiming to prove that addition of oral clarithromycin to a β-lactam rapidly attenuates the high inflammatory burden of the host in CAP.

NCT ID: NCT04664556 Recruiting - Mortality Clinical Trials

Invasive Pneumococcal Disease Study

Start date: January 1, 2010
Study type: Observational

After 7 then 13 valent pneumococcal conjugate vaccine implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.

NCT ID: NCT04645433 Completed - Mortality Clinical Trials

Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit

Start date: March 15, 2020
Study type: Observational

Effect of Favipiravir and Lopinavir-Ritonavir on Mortality in a Tertiary Center Intensive Care Unit: Single Center Experience